Terms: = Kidney tumors AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
694 results:
1. Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Marvaso G; Jereczek-Fossa BA; Zaffaroni M; Vincini MG; Corrao G; Andratschke N; Balagamwala EH; Bedke J; Blanck O; Capitanio U; Correa RJM; De Meerleer G; Franzese C; Gaeta A; Gandini S; Garibaldi C; Gerszten PC; Gillessen S; Grubb WR; Guckenberger M; Hannan R; Jhaveri PM; Josipovic M; Kerkmeijer LGW; Lehrer EJ; Lindskog M; Louie AV; Nguyen QN; Ost P; Palma DA; Procopio G; Rossi M; Staehler M; Tree AC; Tsang YM; Van As N; Zaorsky NG; Zilli T; Pasquier D; Siva S
Lancet Oncol; 2024 May; 25(5):e193-e204. PubMed ID: 38697165
[TBL] [Abstract] [Full Text] [Related]
2. Patient's self-reported quality of life as a prognostic factor in metastatic renal cell carcinoma initially treated with TKI: nomogram proposal.
Lendínez-Cano G; Vilches-Arenas Á; Congregado-Ruíz B; Medina-López R
World J Urol; 2024 Apr; 42(1):267. PubMed ID: 38678165
[TBL] [Abstract] [Full Text] [Related]
3. Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
Roller A; Davydov II; Schwalie PC; Serrano-Serrano ML; Heller A; Staedler N; Ferreira CS; Dietmann G; Klaman I; Valdeolivas A; Korski K; Cannarile MA
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649280
[TBL] [Abstract] [Full Text] [Related]
4. Challenges and technical aspects in the management of muscle invasive bladder cancer as retrograde radical cystectomy with ileal conduit.
Nusrat NB; Rehman AU; Zafar N; Muhammad S; Bajwa SI; Imtiaz S
J Pak Med Assoc; 2024 Mar; 74(3):513-518. PubMed ID: 38591289
[TBL] [Abstract] [Full Text] [Related]
5. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP; Tao Y; Licitra L; Burtness B; Tahara M; Rischin D; Alves G; Lima IPF; Hughes BGM; Pointreau Y; Aksoy S; Laban S; Greil R; Burian M; Hetnał M; Delord JP; Mesía R; Taberna M; Waldron JN; Simon C; Grégoire V; Harrington KJ; Swaby RF; Zhang Y; Gumuscu B; Bidadi B; Siu LL;
Lancet Oncol; 2024 May; 25(5):572-587. PubMed ID: 38561010
[TBL] [Abstract] [Full Text] [Related]
6. Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy.
de Angelis M; Morra S; Scheipner L; Siech C; Jannello LMI; Baudo A; Goyal JA; Tian Z; Longo N; Ahyai S; de Cobelli O; Chun FKH; Saad F; Shariat SF; Carmignani L; Montorsi F; Briganti A; Karakiewicz PI
World J Urol; 2024 Mar; 42(1):193. PubMed ID: 38530480
[TBL] [Abstract] [Full Text] [Related]
7. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
[TBL] [Abstract] [Full Text] [Related]
8. [Ultrasound-guided percutaneous thermal ablation assisted by artificial ascites and soft tissue edema in the treatment of special-region hepatic tumors].
Feng L; Wang Y; Niu LJ
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):155-160. PubMed ID: 38418190
[No Abstract] [Full Text] [Related]
9. Survival assessment of nephron-sparing surgery or radical nephrectomy in children with unilateral Wilms tumor receiving adjuvant chemotherapy: a retrospective cross-sectional study.
Wu XW; Zhou PP; Dong Q
Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1095-1102. PubMed ID: 38375715
[TBL] [Abstract] [Full Text] [Related]
10. Regional differences in upper tract urothelial carcinoma patients across the United States.
Morra S; Scheipner L; Baudo A; Jannello LMI; de Angelis M; Siech C; Goyal JA; Touma N; Tian Z; Saad F; Califano G; la Rocca R; Capece M; Shariat SF; Ahyai S; Carmignani L; de Cobelli O; Musi G; Briganti A; Chun FKH; Longo N; Karakiewicz PI
Urol Oncol; 2024 May; 42(5):162.e1-162.e10. PubMed ID: 38336499
[TBL] [Abstract] [Full Text] [Related]
11. BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.
Yuce TH; Ak G; Metintas S; Dundar E; Roe OD; Panou V; Metintas M
J Cancer Res Clin Oncol; 2024 Jan; 150(2):38. PubMed ID: 38280040
[TBL] [Abstract] [Full Text] [Related]
12. Network meta-analysis of second line and beyond treatment options in metastatic clear cell renal cell carcinoma.
Obeng-Kusi M; Kreutzfeldt JJ; Estrada-Mendizabal RJ; Choi BM; Abraham I; Recio-Boiles A
Urol Oncol; 2024 Feb; 42(2):32.e1-32.e8. PubMed ID: 38216444
[TBL] [Abstract] [Full Text] [Related]
13. Oncological and functional outcomes of patients who underwent open partial nephrectomy for kidney tumor.
Bosnalı E; Baynal EA; Çınar NB; Akdas EM; Telli E; Yaprak Bayrak B; Teke K; Yılmaz H; Dillioğlugil Ö; Kara Ö
Arch Ital Urol Androl; 2023 Dec; 95(4):12130. PubMed ID: 38193219
[TBL] [Abstract] [Full Text] [Related]
14. Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS).
Siva S; Louie AV; Kotecha R; Barber MN; Ali M; Zhang Z; Guckenberger M; Kim MS; Scorsetti M; Tree AC; Slotman BJ; Sahgal A; Lo SS
Lancet Oncol; 2024 Jan; 25(1):e18-e28. PubMed ID: 38181809
[TBL] [Abstract] [Full Text] [Related]
15. Percutaneous cryoablation of 100 anterior renal tumors: safety and technical success.
Raja J; Pigg R; Li Y; Savage C; Caridi TM; Huang J; Gunn AJ
Abdom Radiol (NY); 2024 Mar; 49(3):919-926. PubMed ID: 38150142
[TBL] [Abstract] [Full Text] [Related]
16. Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.
Grande E; Arranz JÁ; De Santis M; Bamias A; Kikuchi E; Del Muro XG; Park SH; De Giorgi U; Alekseev B; Mencinger M; Izumi K; Schutz FA; Puente J; Li JR; O'Donnell PH; Kalebasty AR; Ye D; Mariathasan S; Bene-Tchaleu F; Bernhard S; Lee C; Davis ID; Galsky MD
Lancet Oncol; 2024 Jan; 25(1):29-45. PubMed ID: 38101433
[TBL] [Abstract] [Full Text] [Related]
17. Combination therapies in patients with favorable risk metastatic renal cell Carcinoma: A Systematic Review and Meta-Analysis.
Bolek H; Yekedüz E; Ürün Y
Cancer Treat Rev; 2024 Jan; 122():102667. PubMed ID: 38101099
[TBL] [Abstract] [Full Text] [Related]
18. Single-Port Robotic Radical Prostatectomy Using Transvesical and Transperineal Access in Patients with a Hostile Abdomen.
Ferguson EL; Ramos-Carpinteyro R; Soputro N; Chavali JS; Geskin A; Kaouk JH
J Endourol; 2024 Feb; 38(2):150-158. PubMed ID: 38069569
[No Abstract] [Full Text] [Related]
19. Acupuncture vs Massage for Pain in Patients Living With Advanced Cancer: The IMPACT Randomized Clinical Trial.
Epstein AS; Liou KT; Romero SAD; Baser RE; Wong G; Xiao H; Mo Z; Walker D; MacLeod J; Li Q; Barton-Burke M; Deng GE; Panageas KS; Farrar JT; Mao JJ
JAMA Netw Open; 2023 Nov; 6(11):e2342482. PubMed ID: 37962891
[TBL] [Abstract] [Full Text] [Related]
20. Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study.
Yan XQ; Ye MJ; Zou Q; Chen P; He ZS; Wu B; He DL; He CH; Xue XY; Ji ZG; Chen H; Zhang S; Liu YP; Zhang XD; Fu C; Xu DF; Qiu MX; Lv JJ; Huang J; Ren XB; Cheng Y; Qin WJ; Zhang X; Zhou FJ; Ma LL; Guo JM; Ding DG; Wei SZ; He Y; Guo HQ; Shi BK; Liu L; Liu F; Hu ZQ; Jin XM; Yang L; Zhu SX; Liu JH; Huang YH; Xu T; Liu B; Sun T; Wang ZJ; Jiang HW; Yu DX; Zhou AP; Jiang J; Luan GD; Jin CL; Xu J; Hu JX; Huang YR; Guo J; Zhai W; Sheng XN
Ann Oncol; 2024 Feb; 35(2):190-199. PubMed ID: 37872020
[TBL] [Abstract] [Full Text] [Related]
[Next]
